Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06010732 · ClinicalTrials.gov registry record · Phase 3

In Situ Comparison of the Remineralization Potential of Optimized Fluoride Dentifrice With Control Fluoride Dentifrice

A Phase 3 study of Caries, sponsored by Indiana University.

Completed
Registry status
Phase 3
Development phase
52
Enrollment target
1
Study location

NCT06010732 is a Phase 3 study of Caries that has completed, run by Indiana University. The registered enrollment target is 52 participants, roughly in line with the 53-participant average among 7 other Caries trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06010732, a Phase 3 study of Caries, has completed, sponsored by Indiana University.

COMPLETED
Registry status
Phase 3
Development phase
52 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the remineralization potential of an optimized fluoride dentifrice to a control fluoride dentifrice in an in situ caries model.

Conditions Studied

Interventions

  • DRUG 0 ppm F (placebo, negative control)
  • DRUG 1100 ppm F as sodium fluoride (positive control)
  • DRUG 1100 ppm F as sodium fluoride Test Product

Study Locations (1)

Indiana

  • Indiana University School of dentistry, Oral Health Research institute 415 Lansing Street - Indianapolis

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2023-10-02
Est. Completion 2024-02-22
Phase Phase 3

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT06010732

The ClinicalTrials.gov registry entry for NCT06010732 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 53-participant average among 7 other Caries trials with a reported enrollment target. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Caries appearing as the primary indexed condition, and to 3 interventions - of which 0 ppm F (placebo, negative control) is the first listed.

NCT06010732 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT06010732 about?

NCT06010732 is a clinical study titled "In Situ Comparison of the Remineralization Potential of Optimized Fluoride Dentifrice With Control Fluoride Dentifrice". The purpose of this study is to compare the remineralization potential of an optimized fluoride dentifrice to a control fluoride dentifrice in an in situ caries model.

What is the current status of trial NCT06010732?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 52 participants. The study started on 2023-10-02. Estimated completion is 2024-02-22.

What conditions does trial NCT06010732 study?

This clinical trial studies the following conditions: Caries.

What interventions are being tested in trial NCT06010732?

The interventions under investigation include: 0 ppm F (placebo, negative control) (DRUG), 1100 ppm F as sodium fluoride (positive control) (DRUG), 1100 ppm F as sodium fluoride Test Product (DRUG).

Who is sponsoring clinical trial NCT06010732?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06010732 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Caries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.